Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model

BACKGROUND: Using killed microorganisms or their parts to stimulate immunity for cancer treatment dates back to the end of 19(th) century. Since then, it undergone considerable development. Our novel approach binds ligands to the tumor cell surface, which stimulates tumor phagocytosis. The therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Caisová, Veronika, Vieru, Andra, Kumžáková, Zuzana, Glaserová, Simona, Husníková, Hana, Vácová, Nikol, Krejčová, Gabriela, Paďouková, Lucie, Jochmanová, Ivana, Wolf, Katherine I., Chmelař, Jindřich, Kopecký, Jan, Ženka, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142338/
https://www.ncbi.nlm.nih.gov/pubmed/27927165
http://dx.doi.org/10.1186/s12885-016-2982-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142338/
https://www.ncbi.nlm.nih.gov/pubmed/27927165
http://dx.doi.org/10.1186/s12885-016-2982-x

Ejemplares similares